Administration of anti-IL-25 antibodies in mice with ovalbumin (44) or HDM and adenoviral Smad2 overexpression-induced asthma (45) significantly decreased the Th2 immune responses and attenuated AHR and airway tissue remodeling. This evidence concerns the gene IL25 and asthma.